Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmanex does not market lovastatin in guise of dietary supplement -- company to FDA.

This article was originally published in The Tan Sheet

Executive Summary

PHARMANEX IS NOT MARKETING LOVASTATIN in the guise of a dietary supplement as Cholestin, the company asserts in an Oct. 29 filing with FDA. "Rather, Cholestin is a natural dietary supplement composed entirely of red yeast rice made by the traditional Chinese method," the company maintains. "Many of these traditional red yeast rice products naturally contain a range of HMG-CoA reductase inhibitors -- including mevinolin (which the agency equates chemically with lovastatin) -- as well as unsaturated fatty acids" and other constituents which contribute to the product's "functionality," Pharmanex states.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel